Source: International Journal of Technology Assessment in Health Care. Unidade: FCF
Subjects: DOENÇAS RARAS, MEDICAMENTO, AVALIAÇÃO DE TECNOLOGIAS DA SAÚDE, SISTEMA ÚNICO DE SAÚDE
ABNT
BIGLIA, Luiza Vasconcelos et al. Development of a value assessment framework for Health Technology Assessment in rare diseases drugs: insights from a Delphi study in Brazil. International Journal of Technology Assessment in Health Care, v. 41, n. 1, p. 1-12, 2025Tradução . . Disponível em: https://dx.doi.org/10.1017/S0266462324004835. Acesso em: 27 jan. 2026.APA
Biglia, L. V., Felippini, A., Ribeiro, T. B., Lima, T. de M., & Aguiar, P. M. (2025). Development of a value assessment framework for Health Technology Assessment in rare diseases drugs: insights from a Delphi study in Brazil. International Journal of Technology Assessment in Health Care, 41( 1), 1-12. doi:10.1017/S0266462324004835NLM
Biglia LV, Felippini A, Ribeiro TB, Lima T de M, Aguiar PM. Development of a value assessment framework for Health Technology Assessment in rare diseases drugs: insights from a Delphi study in Brazil [Internet]. International Journal of Technology Assessment in Health Care. 2025 ; 41( 1): 1-12.[citado 2026 jan. 27 ] Available from: https://dx.doi.org/10.1017/S0266462324004835Vancouver
Biglia LV, Felippini A, Ribeiro TB, Lima T de M, Aguiar PM. Development of a value assessment framework for Health Technology Assessment in rare diseases drugs: insights from a Delphi study in Brazil [Internet]. International Journal of Technology Assessment in Health Care. 2025 ; 41( 1): 1-12.[citado 2026 jan. 27 ] Available from: https://dx.doi.org/10.1017/S0266462324004835
